Piramal Healthcare Says Reports Of Sell-off To GSK Or Sanofi-Aventis “Totally Unfounded”

MUMBAI - Indian drug maker Piramal Healthcare has denied sell-off talks with GlaxoSmithKline or Sanofi-Aventis as is reported in the international media